In estrogen-receptor-positive breast cancer cells, such IGF-1R-independent actions of IGFBP-2 were found to be dependent on the presence of ERα, as silencing ERα eliminated these intrinsic effects of IGFBP-2 [19]. Here, ESR1 is linked to breast carcinoma.